Interim

IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones

admin June 29, 2025 0

June 23, 2025 8:30 AM EDT | Source: IR-MED, Inc. PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing...

IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones

admin June 24, 2025 0

PressureSafe™, IR-MED's lead product, demonstrated 94% sensitivity in assessing tissue at risk for pressure injuries prior to visible skin breakdownTechnology...

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

admin January 20, 2025 0

Three-month interim data from first-of-its-kind trial demonstrate that the combination of Sculptra® and Restylane® Lyft™ or Contour™ effectively improved the...

Interim

IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones

IR-MED Reports Positive Interim Results from U.S. Clinical Study of PressureSafe(TM) for Pressure Injury Assessment Across Diverse Skin Tones

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

Doctors Seek Faster AI Adoption in Nigeria’s Healthcare System

‘Behind the Blue’: Edward Cantu on expanding lung transplant care in Kentucky

Wireless Skin Sensor Prevents Pressure Ulcers Continuously

Bill of the Month: Not serious enough to turn on the siren, toddler’s 39-mile ambulance ride still cost over $9,000 | Lifestyle

Causes, Symptoms & Treatment Options

You may have missed